Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Lung Cancer (Amsterdam, Netherlands)|January 12, 2020
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intentMichela Buglione, Barbara Alicja Jereczek-Fossa, Marco Lorenzo Bonù, et al.
Magma (New York, N.Y.)|December 17, 2021
A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissueJan Petr, Louise Hogeboom, Pavel Nikulin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 23, 2022
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groupsGabriella Macchia, Alessia Nardangeli, Concetta Laliscia, et al.
Radiation Oncology (London, England)|August 27, 2025
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRTAndrei Fodor, Laura Giannini, Miriam Torrisi, et al.
European Urology Oncology|April 3, 2023
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter StudyPaul Archer, Giulia Marvaso, Beatrice Detti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 7, 2022
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiationCesare Cozzarini, Michela Olivieri, Alessandro Magli, et al.
European Urology Oncology|February 7, 2025
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter SeriesLudwige Abancourt, Muhammad Ali, Magali Quivrin, et al.
Gynecologic Oncology|January 25, 2024
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancerGabriella Macchia, Savino Cilla, Donato Pezzulla, et al.
The Oncologist|February 12, 2020
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO GroupsGabriella Macchia, Roberta Lazzari, Nicoletta Colombo, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 2025
Treatment of Oligometastatic Parenchymal Lesions in Ovarian Cancer With Stereotactic Ablative Radiation Therapy: A Multicenter Prospective Phase 2 Trial (MITO RT3/RAD)Gabriella Macchia, Donato Pezzulla, Maura Campitelli, et al.
Pageof 8